(A) C57BL/6 mice (12 per group) were vaccinated with
106P. chabaudi prbcs attenuated with centanamycin or
injected with saline. Phenotypes of blood CD4+ and CD8+ cells were
assessed on days 5 and 21 after vaccination. Values for means of the saline group were
subtracted from values for each vaccinated mouse. Each circle represents 1 mouse.
Horizontal bars represent means. One sample t test was performed
comparing values to the saline mean of zero. (B) Three A/J mice were
immunized with 3 doses of vaccine (each, 106 centanamycin-attenuated
P. chabaudi prbcs), and spleen cells from these and a naive mouse
were collected 8 weeks after the last immunization and cultured with indicated antigens;
uptake of 3H thymidine was determined after 72 hours as described in Methods.
(C) C57BL/6 mice (5 per group) were vaccinated with
106P. chabaudi prbcs or equivalent nrbcs attenuated with
centanamycin and sacrificed on day 5. Spleen cells were stimulated in vitro for 4 hours
with PMA and ionomycin in the presence of BFA and stained for IFN-γ. Percentage
that was IFN-γ positive was determined by subtracting isotype control and values
from mice injected with saline for CD4 and CD8 populations. (D) Three A/J
mice were immunized with 3 doses of vaccine (each, 106
centanamycin-attenuated P. chabaudi prbcs), and spleen cells from these
mice were collected 50 days after the last immunization, cultured with indicated
antigens, and after 72 hours culture, supernatants collected and use for cytokine bead
analysis as described in Methods. (E) C57BL/6 mice (CD45.2, 5 per group)
were adoptively transferred with OT-II T cells (CD45.1), and 1 group received ovalbumin
peptide 323–339 mixed with LPS i.p. 24 hours later, mice were immunized i.v. with
106P. chabaudi prbcs or equivalent nrbcs attenuated with
centanamycin. Mice were bled on day 6 after immunization and the phenotype of donor and
recipient cells determined by flow cytometry. Percentages were calculated by subtracting
values from mice receiving OT-II cells alone.